Inactive Instrument
IRLAB Therapeutics AB Stock Nasdaq Stockholm
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 199M 20.96M 18.19M 17.03M 15.58M 29.42M 2B 29.8M 78.2M 998M 78.7M 76.99M 3.32B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 199M 20.96M 18.19M 17.03M 15.58M 29.42M 2B 29.8M 78.2M 998M 78.7M 76.99M 3.32B | EV / Sales 2026 * |
1.95x | EV / Sales 2027 * | 1.41x |
| Free-Float |
81.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
| Chairman | 68 | 2023-02-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.89% | +3.20% | +59.70% | +165.18% | 1,062B | |
| -0.24% | +0.45% | +50.64% | +52.02% | 619B | |
| -0.95% | -5.26% | +24.23% | +65.08% | 431B | |
| +2.33% | +5.66% | +49.98% | +41.06% | 358B | |
| +1.25% | +0.19% | +36.31% | +41.17% | 293B | |
| +1.24% | -4.88% | +9.74% | +10.38% | 247B | |
| -0.73% | +4.44% | +42.22% | +66.41% | 219B | |
| +4.28% | +0.10% | -0.66% | -43.78% | 200B | |
| -0.68% | -0.32% | +18.66% | +66.32% | 162B | |
| Average | +0.96% | -1.90% | +32.31% | +51.54% | 399.14B | |
| Weighted average by Cap. | +0.52% | -0.83% | +41.28% | +78.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.73M 9.31M 8.72M 7.98M 15.06M 1.02B 15.25M 40.03M 511M 40.29M 39.41M 1.7B | 142M 14.92M 12.94M 12.12M 11.09M 20.93M 1.42B 21.2M 55.65M 710M 56M 54.79M 2.36B |
| Net income | -32.6M -3.43M -2.98M -2.79M -2.55M -4.81M -327M -4.88M -12.79M -163M -12.88M -12.6M -543M | 33.3M 3.5M 3.04M 2.85M 2.6M 4.92M 334M 4.98M 13.07M 167M 13.15M 12.87M 555M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
Select your edition
All financial news and data tailored to specific country editions
